Characteristics | Number (n = 22) | Percentage (%) |
Age |
|
|
median 51.5 (range 20 - 65) |
|
|
≤45 | 8 | 36.4% |
>45 | 14 | 63.6% |
Sex |
|
|
Male | 16 | 72.7% |
Female | 6 | 27.3% |
ECOG performance status |
|
|
1 | 15 | 68.2% |
2 | 7 | 31.8% |
Site of primary tumors |
|
|
frontal | 7 | 31.8% |
temporal | 14 | 63.6% |
parietal | 15 | 68.2% |
occipital | 2 | 9.1% |
ventricular | 1 | 4.5% |
Primary surgery |
|
|
Biopsy | 3 | 13.6% |
Subtotal excision | 17 | 77.3% |
Maximal safe resection | 2 | 9.1% |
Primary systemic treatment |
|
|
Temozolamide | 14 | 63.6% |
PCV protocol | 8 | 36.4% |